AU2013211833B2 - Influenza C virus and vaccine - Google Patents

Influenza C virus and vaccine Download PDF

Info

Publication number
AU2013211833B2
AU2013211833B2 AU2013211833A AU2013211833A AU2013211833B2 AU 2013211833 B2 AU2013211833 B2 AU 2013211833B2 AU 2013211833 A AU2013211833 A AU 2013211833A AU 2013211833 A AU2013211833 A AU 2013211833A AU 2013211833 B2 AU2013211833 B2 AU 2013211833B2
Authority
AU
Australia
Prior art keywords
virus
influenza
seq
vaccine
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013211833A
Other languages
English (en)
Other versions
AU2013211833A1 (en
AU2013211833A2 (en
Inventor
Emily A. Collin
Benjamin M. Hause
Randy R. Simonson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Boehringer Ingelheim Animal Health USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Animal Health USA Inc filed Critical Boehringer Ingelheim Animal Health USA Inc
Publication of AU2013211833A1 publication Critical patent/AU2013211833A1/en
Publication of AU2013211833A2 publication Critical patent/AU2013211833A2/en
Application granted granted Critical
Publication of AU2013211833B2 publication Critical patent/AU2013211833B2/en
Assigned to Boehringer Ingelheim Animal Health USA Inc. reassignment Boehringer Ingelheim Animal Health USA Inc. Request for Assignment Assignors: NEWPORT LABORATORIES, INC.
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2013211833A 2012-01-27 2013-01-28 Influenza C virus and vaccine Ceased AU2013211833B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/385,004 2012-01-27
US13/385,004 US9278999B2 (en) 2012-01-27 2012-01-27 Influenza C virus and vaccine
PCT/US2013/023441 WO2013112995A1 (en) 2012-01-27 2013-01-28 Influenza c virus and vaccine

Publications (3)

Publication Number Publication Date
AU2013211833A1 AU2013211833A1 (en) 2014-09-18
AU2013211833A2 AU2013211833A2 (en) 2014-09-25
AU2013211833B2 true AU2013211833B2 (en) 2017-09-14

Family

ID=47714564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013211833A Ceased AU2013211833B2 (en) 2012-01-27 2013-01-28 Influenza C virus and vaccine

Country Status (13)

Country Link
US (1) US9278999B2 (enExample)
EP (1) EP2807184A1 (enExample)
JP (1) JP6257529B2 (enExample)
CN (1) CN104203972A (enExample)
AU (1) AU2013211833B2 (enExample)
BR (1) BR112014018278B1 (enExample)
CA (1) CA2862328C (enExample)
HK (1) HK1201283A1 (enExample)
MX (1) MX360831B (enExample)
NZ (1) NZ629378A (enExample)
PH (1) PH12014501688A1 (enExample)
RU (1) RU2656186C2 (enExample)
WO (1) WO2013112995A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015000789A (es) * 2012-07-19 2015-05-07 Zoetis Llc Composiciones de virus de la gripe bovina.
AR111770A1 (es) 2017-05-05 2019-08-21 Elanco Us Inc Vacuna para enfermedad respiratoria bovina
CN111363855A (zh) * 2020-04-30 2020-07-03 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种同时检测a、d型流感病毒的成套试剂、试剂盒及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119782A1 (en) * 2000-06-29 2003-06-26 Cham Bill E. Method of treating and preventing infectious diesases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004161781A (ja) * 1992-03-03 2004-06-10 Dai Ichi Seiyaku Co Ltd 経口ワクチン
CA2671869A1 (en) * 2006-12-15 2008-06-26 Schering-Plough Ltd. Method for replicating influenza virus in culture
TW200927928A (en) 2007-09-24 2009-07-01 Nobilon Internat B V Inactivated influenza vaccine
US20090110698A1 (en) * 2007-10-31 2009-04-30 Newport Laboratories, Inc. Method of determining vaccine compliance
RU2428476C1 (ru) * 2010-06-21 2011-09-10 Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) Реассортантный штамм вируса гриппа rn 1/09-swine a(h7n1) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119782A1 (en) * 2000-06-29 2003-06-26 Cham Bill E. Method of treating and preventing infectious diesases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ELLIOTT, RM et al "Protein and nucleic acid analyses of influenza C viruses isolated from pigs and man.", VACCINE (1985), VOL 3 Supplement: pages 82-188 *
KIMURA, H et al; "Interspecies transmission of influenza C virus between humans and pigs", Virus Research, Vol 48, no. 1, 1 April 1997 (1997-04-01), pages 71-79 *
Margaret Hessen: "In the clinic. Influenza.", Annals of Internal Medicine, Vol. 151, no. 9, 1 November 2009 (2009-11-01), pages ICT5-1 *

Also Published As

Publication number Publication date
JP2015506949A (ja) 2015-03-05
AU2013211833A1 (en) 2014-09-18
CN104203972A (zh) 2014-12-10
BR112014018278A2 (pt) 2019-04-02
US20130195915A1 (en) 2013-08-01
HK1201283A1 (en) 2015-08-28
RU2656186C2 (ru) 2018-05-31
CA2862328C (en) 2021-08-31
PH12014501688A1 (en) 2014-10-20
NZ629378A (en) 2017-06-30
CA2862328A1 (en) 2013-08-01
RU2014134850A (ru) 2016-03-20
BR112014018278B1 (pt) 2023-01-17
WO2013112995A1 (en) 2013-08-01
US9278999B2 (en) 2016-03-08
EP2807184A1 (en) 2014-12-03
MX360831B (es) 2018-11-16
JP6257529B2 (ja) 2018-01-10
MX2014009022A (es) 2015-03-03
AU2013211833A2 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
Polatoğlu et al. COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
AU2022259826B2 (en) Methods of detection and removal of rhabdoviruses from cell lines
Crawford et al. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes
US7776521B1 (en) Coronavirus isolated from humans
Thabti et al. Detection of a novel border disease virus subgroup in Tunisian sheep
KR20090088944A (ko) 배양물 속에서 인플루엔자 바이러스를 복제하는 방법
Tang et al. A multiplex RT-PCR assay for detection and differentiation of avian H3, H5, and H9 subtype influenza viruses and Newcastle disease viruses
Barr et al. Reassortants in recent human influenza A and B isolates from South East Asia and Oceania
Nogales et al. Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use
AU2013211833B2 (en) Influenza C virus and vaccine
CN114835778A (zh) 一种h9n2亚型aiv mhc b2限制性表位肽及其应用
Biswal et al. Evaluation of FTA® card for the rescue of infectious foot-and-mouth disease virus by chemical transfection of extracted RNA in cultured cells
Lugovtsev et al. Mutational pattern of influenza B viruses adapted to high growth replication in embryonated eggs
Lee et al. Development of one-step multiplex RT-PCR method for simultaneous detection and differentiation of foot-and-mouth disease virus serotypes O, A, and Asia 1 circulating in Vietnam
CN101610787A (zh) 在培养物中复制流感病毒的方法
US10080794B2 (en) Swine influenza viruses and constructs and uses thereof
Guercio et al. Pandemic influenza A/H1N1 virus in a swine farm house in Sicily, Italy
KR101339162B1 (ko) 돼지 인플루엔자 바이러스 감염의 예방 또는 치료방법
Aileni et al. Biotechnological perspectives to combat the COVID-19 pandemic: precise diagnostics and inevitable vaccine paradigms. Cells. 2022; 11: 1182
CN107753943A (zh) 一种h7亚型禽流感dna疫苗及其制备方法
KR101345787B1 (ko) 신규한 돼지 인플루엔자 바이러스 ａ ｈ1ｎ1 및 그의 용도
Kaore et al. Laboratory diagnosis of novel H1N1 virus
KR20130116706A (ko) 신규한 ｈ3ｎ8 말 인플루엔자 바이러스
El-abassy et al. MOLECULAR SURVEY OF AVIAN RESPIRATORY VIRUSES IN COMMERCIAL BROILER AND LAYER FLOCKS WITH RESPIRATORY MANIFESTATIONS IN KAFRELSHEIKH GOVERNORATE
Khangd et al. Development of one-step multiplex RT-PCR method for simultaneous detection and differentiation of foot-and-mouth disease virus serotypes O, A, and Asia 1 circulating in Vietnam

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 28 AUG 2014

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.

Free format text: FORMER OWNER(S): NEWPORT LABORATORIES, INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired